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Background: Maternal asthma during pregnancy is considered an environmental risk 
factor for asthma development in children. Immunoglobulin G (IgG) antibodies that 
are transferred from the mother to the fetus are known to act in a pro- or anti-inflam-
matory manner depending on their glycosylation status.
Objective: Using a mouse model, we examined how maternal allergic airway inflam-
mation during pregnancy influenced offspring experimental asthma severity, as well 
as maternal and offspring serum IgG antibody glycosylation patterns. Additionally, 
the effects of maternal and offspring exposure to the same or different allergens 
were investigated.
Methods: Female mice were either sham sensitized or sensitized to casein (CAS) or 
ovalbumin (OVA) before mating. Subsequently, allergic lung inflammation was induced 
in pregnant dams via aerosol allergen challenge (sham, CAS or OVA). After weaning, 
pups were subjected to an experimental asthma protocol using OVA. Asn-297 IgG 
glycosylation was analysed in maternal and offspring serum.
Results: When mothers and offspring were sensitized to the same allergen (OVA-
OVA), offspring had more severe experimental asthma. This was evidenced by altered 
antibody concentrations, increased bronchoalveolar lavage inflammatory cell influx 
and decreased lung tissue and lung draining lymph node regulatory T cell percent-
ages. When mothers and offspring were sensitized to different allergens (CAS-OVA), 
this phenotype was no longer observed. Additionally, maternal serum from allergic 
mothers had significantly higher levels of pro-inflammatory IgG1, shown by decreased 
galactosylation and sialylation at the Asn-297 glycosylation site. Similar glycosylation 
patterns were observed in the serum of adult allergic offspring from allergic mothers.
Conclusions and Clinical Relevance: We observed a strong association between ma-
ternal experimental asthma during pregnancy, increased offspring airway inflamma-
tion and pro-inflammatory IgG glycosylation patterns in mothers and offspring. IgG 
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1  | INTRODUC TION
Asthma is a chronic obstructive airway disease characterized by air-
way inflammation and hyperreactivity leading to recurring episodes of 
respiratory symptoms including cough and shortness of breath. More 
than 300 million people around the world suffer from asthma, and its 
incidence is increasing in many countries, especially among children.1,2 
Though parental history plays a major role in asthma development in 
children, genetics alone cannot explain why asthma frequency has 
been increasing over the past decades.3 In fact, exogenous risk factors 
during pregnancy and early life are described to play a crucial role in 
asthma pathogenesis.4 Supporting this, retrospective human studies 
indicate that maternal asthma represents a stronger risk factor than 
paternal asthma.5-7 Moreover, mouse models demonstrate that mater-
nal asthma exacerbation during pregnancy results in increased asthma 
severity in the offspring.8-10 However, the underlying mechanisms that 
contribute to this phenomenon remain incompletely understood.
During pregnancy and breastfeeding, transfer of maternal 
immunoglobulin G (IgG) antibodies protects the offspring from 
pathogens, while the humoral immune response is still ineffi-
cient. Importantly, IgG antibodies can act either pro- or anti-in-
flammatory, depending on complex N-glycans attached to the 
asparagine (Asn)-297 residue on the fragment crystallizable (Fc) 
region.11 Structurally, this N-glycan consists of a core containing 
four N-acetylglucosamine residues and three mannose molecules, 
shown in Figure 1A. Integration of galactose and sialic acid resi-
dues on these branched carbohydrate chains alters the structure 
of the antibody, changing antibody receptor binding properties 
and increasing the anti-inflammatory properties of the mole-
cule,12,13 shown in Figure 1B.
IgG glycosylation patterns have been correlated with disease 
severity in humans and serve as a therapeutic target. For instance, 
in autoimmune diseases, exacerbations are characterized by an in-
creased frequency of agalactosylated IgG (G0) and a decreased fre-
quency of sialic acid.14-16 This imbalance of IgG glycosylation can be 
therapeutically compensated by administration of high dose intra-
venous immunoglobulin (IVIG), which leads to an increase in anti-in-
flammatory sialylated antibodies.17 Importantly, in allergen-specific 
Award Number: CO-1058/3-1 and SFB-
TR84 C3 and C6 glycosylation is not a standard measurement in the clinical setting, and we argue that 
it may be an important parameter to include in future clinical studies.
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F I G U R E  1   Schematic of IgG1 
glycosylation. A, Illustration of an IgG 
molecule showing the two Asn-297 
N-liked glycosylation sites in the Fc region 
of the antibody. The core component 
of the glycan molecule consists of four 
N-acetylglucosamine residues (black) and 
three branched mannose molecules (grey). 
This core structure can be modified by 
the addition of a fucose (red), or galactose 
(blue) and sialic acid (orange). The inset 
shows a fucosylated, galactosylated 
and sialylated N-glycan (G2S2). B, 
Representation of the different Asn-297 
glycosylation structures reported in this 
study. All structures contain a core fucose. 
Pro-inflammatory agalactosylated glycan: 
G0. Anti-inflammatory galactose and 
sialic acid containing glycans: G1S1, G2S1, 
G3S1, G2S2
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immunotherapy, successful tolerance induction is associated with 
generation of sialylated antigen-specific IgG.18,19
IgG glycosylation is known to be influenced by the environment11 
and thus directly reflects the physiological status of an individual. In 
the case of maternal asthma during pregnancy, since the developing 
fetus is exposed to transferred IgG from the mother, it is important 
to consider both IgG concentrations and glycosylation status. Upon 
transfer to the fetus or neonate, these pro- or anti-inflammatory 
signals could strongly influence immune system development and 
predispose the offspring to inflammation or allergy susceptibility. 
Studies have shown that the levels of galactosylated and sialylated 
serum IgG increase during pregnancy and decrease postpartum.20 
However, to our knowledge, this is the first study examining IgG 
glycosylation in relation to maternal asthma during pregnancy and 
offspring asthma susceptibility.
Here, we demonstrate that asthma exacerbation during preg-
nancy alters maternal serum IgG1 and IgG3 glycosylation patterns 
towards a pro-inflammatory phenotype. We further show that these 
maternal IgG antibody glycosylation patterns persisted in adult al-
lergic offspring and were associated with increased inflammatory 
responses in offspring experimental asthma.
2  | METHODS
2.1 | Animals
Eight-week-old female BALB/c mice were obtained from Janvier 
Labs (Le Genest-Saint-Isle, France) and housed four animals per 
cage in a 12/12-h light/dark cycle. Food and water were available 
ad libitum. All animal experiments were approved by local authori-
ties and were performed in accordance with German and interna-
tional guidelines.
2.2 | Experimental design
2.2.1 | Allergen sensitization and challenge—Dams
Using an adjuvant-free, experimental asthma protocol,21 8-week-old 
female BALB/c mice were subcutaneously sensitized once weekly for 
three weeks (maternal age 8, 9 and 10 weeks) with either 10 µg casein 
(CAS) (Merck) or 10 µg ovalbumin (OVA) (grade VI, Merck) in 200 µL 
phosphate-buffered saline (PBS). Controls were sham sensitized with 
PBS (Figure 2A,B). After a two-week rest period, 12-week-old sen-
sitized females were mated with non-sensitized, male BALB/c mice, 
and visualization of a mucous plug was considered gestation day (G)0. 
On G6, G8, G10, G12, G14 and G16 pregnant mice were exposed for 
20 minutes to an aerosol of either 1% CAS or 1% OVA to elicit the 
asthma phenotype during pregnancy. Control pregnant mice were 
sham exposed to PBS aerosol. Pups were born and weaned at 21 days 
of age. Since taking blood can have a substantial impact on mouse 
physiology,22 and we did not want to interfere with the pregnant mice 
or the possible offspring outcome, we chose maternal recall challenge 
as a method to evaluate maternal allergic airway inflammation. Ten 
days after offspring weaning, the maternal asthma phenotype was 
assessed by exposing dams to an aerosol recall challenge of PBS, CAS 
or OVA, respectively (20 minutes per day for 3 days) (Figure 2A,B).
2.2.2 | Allergen sensitization and challenge—
Offspring
At 21 days of age, offspring were weaned from their mothers 
and immediately sensitized using an adjuvant-free, experimental 
asthma protocol. Specifically, at 21, 28 and 35 days of age, all 
female offspring were subcutaneously sensitized with 10 µg OVA 
(grade VI, Merck) in 200 µL PBS. At 46, 47 and 48 days of age, 
F I G U R E  2   Protocol for testing the effect of maternal asthma during pregnancy on offspring asthma risk. This model allows comparison 
of mothers and offspring that are allergic to different allergens (CAS/OVA) or the same allergen (OVA/OVA). A, Maternal treatment: Before 
mating, female mice were subcutaneously sensitized with either casein (CAS) or ovalbumin (OVA) at 56, 63 and 70 d of age. Control female 
mice were sham-sensitized with phosphate-buffered saline (PBS). After mating, pregnant mice were aerosol challenged with the respective 
allergen (CAS or OVA) or control (PBS) every second day from gestation day (G) 6 to G16. Pups were born, and 10 d after weaning, the 
maternal asthma phenotype was assessed by exposing dams to an aerosol recall challenge of PBS, CAS or OVA, respectively. Offspring 
treatment: At 21, 28 and 35 d of age, offspring were subcutaneously sensitized to OVA. Offspring were aerosol challenged with OVA at 
46, 47 and 48 d of age, and analysis was performed 24 h after the last challenge on offspring day 49. B, Summary of the allergens used for 
maternal and offspring experimental asthma sensitization and challenge
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the asthma phenotype was induced by exposing the offspring for 
20 minutes to a 1% OVA aerosol (Figure 2A,B). In each group, 2 or 
more offspring from a minimum of 6 mothers were used.
2.3 | Airway reactivity
Twenty four hours after the last challenge, offspring airway reac-
tivity was measured in 10 mice from each group. Mice were anes-
thetized by intraperitoneal injection with a mixture of 10 mg/mL 
ketamine (Merial) and 1 mg/mL xylazine (VMD Livestock). A 20-
gauge polyethylene catheter was inserted into the trachea, and 
mice were ventilated with a flexiVent small animal ventilator® 
(SCIREQ) as previously described.23 Lung function was assessed 
at baseline and following increasing doses of aerosolized metha-
choline (0, 1.25, 2.5, 5, 10 and 20 g/L) using a 3-sec broadband 
signal to measure input impedance from 1 to 20.5 Hz and to calcu-
late constant-phase model parameters. Newtonian resistance (Rn) 
was the main parameter measured during the challenge.
2.4 | Bronchoalveolar lavage (BAL) and differential 
cell counts
Blood samples were taken from the orbital sinus of terminally anaesthe-
tized mice, and serum was stored at −80°C. Using a tracheal cannula on 
euthanized mice, BAL was performed once using 1 mL PBS containing 
1 × cOmplete protease inhibitor cocktail (Roche). BAL supernatant was 
stored at −80°C, and total leucocytes were counted with a Neubauer 
chamber. Cytospin preparations were stained with Diff-Quick (Merz & 
Dade), and standard morphological criteria were used to identify cell 
types. Two hundred cells were counted per cytospin by a researcher 
blinded to the sample names.
2.5 | Lung collection and histology
Immediately after BAL, lungs were fixed with 4% formalin and then 
embedded in paraffin. Using a method previously described,24 
4-µm PAS-stained lung sections were microscopically analysed 
using the new Computer Assisted Stereological Toolbox (newCAST, 
Visiopharm) by readers blinded to the study groups. For quantifica-
tion of inflammation, the software randomly selected 100 frames 
of a coronal lung section (40x objective) and superimposed these 
frames by grid of points. Point intercepts on leucocytes were consid-
ered a point of inflammation (PI). Total PI for each lung was collected 
and normalized to the surface area measured.
2.6 | Immunohistochemistry
After deparaffinization and rehydration, 4-µm paraffin-embedded 
lung tissue sections were washed in Tris-buffered saline, followed by 
blocking of endogenous peroxidase via incubation with 3% H2O2 in 
methanol for 30 minutes at room temperature. After incubation with 
5% normal serum, the samples were incubated with anti-FoxP3 primary 
antibody (Clone: FJK-16 – eBioscience) overnight at 4°C. The slides 
were washed and then incubated for 1 hour at room temperature with 
biotinylated goat anti-rat secondary antibody (Vector Laboratories). 
Signal was detected using a liquid DAB + Substrate-Chromogen System 
(Agilent) at room temperature.
2.7 | Antibody quantification
Serum levels of OVA-specific IgE and IgG1 were measured in both 
dams and pups by enzyme-linked immunosorbent assay (ELISA). Nunc 
MaxiSorp flat-bottom 96-well plates (Sigma-Aldrich) were coated with 
20 µg/mL OVA, diluted in NaHCO3 buffer and incubated overnight 
at 4°C. Plates were washed and blocked with PBS-1%BSA buffer for 
2 hours at room temperature. After washing, serum samples were 
added and incubated overnight at 4°C. Plates were then washed and 
incubated with either biotinylated rat anti-mouse IgE (Pharmingen, 
USA) or biotinylated goat anti-mouse IgG1 (Sigma-Aldrich) at room 
temperature for 2 hours. Plates were incubated with streptavidin–
peroxidase for 30 minutes, developed with POD substrate (Sigma-
Aldrich), and the reaction stopped with 2M sulphuric acid. Colour 
development was read with a microplate reader (Bio-Rad) at 450 nm. 
OVA antibody titres of the sample were calculated by comparison 
with standards. For total IgG1 measurement, a similar protocol was 
used with the exception that the plates were coated with 0.5 mg/
mL rat anti-mouse IgG1. CAS-specific IgE and IgG1 were measured 
in mothers by the same procedure as the OVA-specific ELISAs, with 
the exception that plates were coated with 20 mg/mL CAS, and OD 
450 nm was reported.
2.8 | Antibody glycosylation analysis
Subclass-specific mouse IgG N-glycosylation analysis was performed 
as described previously.25 Briefly, IgG was captured from 15 µL of 
murine serum using protein G affinity beads in PBS. Proteins inter-
acted with the beads while being shaken for 1.5 hours, after which the 
beads were washed seven times with 1.5 mL PBS. IgG was eluted with 
100 μL of 100 mmol/L formic acid, and eluates were dried for 2 hours 
in a vacuum concentrator at 60°C. Lyophilized IgG was dissolved in 
40 µL 25 mmol/L ammonium bicarbonate, and 0.2 µg of sequencing 
grade trypsin (Promega) was added. Samples were incubated for 18 h 
at 37°C. Obtained glycopeptides were desalted on C18 beads, dried in 
a vacuum centrifuge and redissolved in 40 µL of ultrapure water. For 
nano-LC-ESI-Qq-TOF analysis, five microlitres of sample was injected 
and separation was achieved on a C18 nano-LC column. For data analy-
sis, files were first converted to.mzXML format using ProteoWizard 
msConvert and processed with LaCy Tools software. Glycopeptide 
peak areas of doubly and triply charged ions were summed and nor-
malized by total area for each subclass detected.
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2.8.1 | Glycan abbreviations
The IgG Asn-297 N-linked glycosylation structures discussed in this 
study are shown in Figure 1B.
2.9 | Statistical analysis
All samples were tested for normal distribution using a Shapiro-Wilk 
normality test. Parametric data were analysed using one-way ANOVA 
and non-parametric data with a Kruskal-Wallis test, followed by 
Dunnett's multiple comparisons test (all groups compared with each 
other). For bronchial responsiveness, airway resistances measured for 
each concentration of methacholine were analysed using two-way 
ANOVA. Data are presented as mean ± SEM. For correlation analysis, 
Pearson's r was calculated and reported with the P value. Calculations 
were performed with GraphPad Prism 8 software.
3  | RESULTS
3.1 | Dams previously challenged during pregnancy 
showed distinct allergic airway inflammation upon 
recall allergen challenge
As expected, dams that were recall challenged with CAS or OVA 
after their offspring were weaned, displayed a clear allergic pheno-
type compared to control dams (sham recall challenged with PBS). 
This was demonstrated by allergen-specific antibody titres in the 
CAS- and OVA-challenged groups (Figure 3A). Regarding allergic 
airway inflammation, both CAS and OVA allergic dams displayed in-
creased numbers of leucocytes in the bronchoalveolar lavage (BAL) 
fluid when compared to controls (Figure 3B). The BAL contained 
significantly increased numbers of eosinophils and lymphocytes in 
the allergic groups; OVA allergic mothers additionally exhibited in-
creased numbers of macrophages. Histological quantification of lung 
tissue inflammation revealed similar profiles for both CAS and OVA 
allergic groups, both of which had a significantly increased number 
of lung tissue leucocytes compared to control dams (Figure 3C,D).
3.2 | Maternal allergen type influences the asthma 
phenotype in allergic offspring
To test the influence of maternal allergic airway inflammation during 
pregnancy on experimental asthma in the offspring, pups from aller-
gic (CAS or OVA) or sham-treated dams were weaned at 21 days of 
age and all offspring were subjected to an adjuvant-free OVA asthma 
protocol (Figure 2A,B). Employing groups in which mothers and off-
spring were allergic to either the same allergen (OVA-OVA) or the 
different allergens (CAS-OVA) additionally allowed us to test how 
the maternal allergen type influenced offspring asthma susceptibil-
ity. Indeed, similarities or differences in allergen between mother and 
offspring were associated with differential antibody concentrations 
in allergic pups. Considering maternal CAS allergy, OVA allergic off-
spring from these dams (CAS-OVA) showed significantly increased 
levels of total IgG1 and OVA-specific IgG1 in the serum when com-
pared with OVA allergic offspring from sham-treated mothers (sham-
OVA). OVA allergic offspring from OVA allergic mothers (OVA-OVA) 
had increased OVA-specific IgG1 and decreased OVA-specific IgE 
compared to sham-OVA offspring (Figure 4A).
Next, we assessed the effect of maternal allergy during pregnancy 
on airway inflammation in the allergic pups. When mothers and off-
spring were sensitized to the same allergen (OVA-OVA), an increase 
in inflammatory cell influx into the offspring BAL was observed. This 
effect was shown to be compartment-specific, as leucocyte numbers 
in lung tissue were comparable between groups (Figure S1A,B). OVA-
OVA offspring BAL contained an increased number of leucocytes 
compared to sham-OVA offspring, which was comprised predomi-
nantly of eosinophils, and to a lesser extent lymphocytes and macro-
phages (Figure 4B). Interestingly, when mothers and offspring were 
sensitized to different allergens (CAS-OVA), there were no differences 
in the offspring BAL when compared with the sham-OVA group.
FoxP3 is a marker of T regulatory (Treg) cells, and allergic asthma 
patients are known to have decreased sputum and blood Treg cell 
numbers.26,27 In our study, immunohistochemical staining revealed 
that when mothers and offspring were both sensitized to the 
same allergen, OVA-OVA offspring showed significantly less Treg 
cells in the lung tissue and lung draining lymph nodes compared 
to the sham-OVA group (Figure 4C,D). This is in accordance with 
the increased eosinophilic cell influx in the BAL of OVA-OVA off-
spring. In contrast, when mothers and offspring were sensitized to 
different allergens (CAS-OVA), no differences in FoxP3 frequency 
were observed compared to sham-OVA offspring. Although we ob-
served clear differences in allergic airway inflammation parameters 
in OVA-OVA compared with sham-OVA offspring, these were not 
correlated with changes in airway reactivity (Figure S1C).
In summary, maternal allergic airway inflammation during pregnancy 
influenced the offspring experimental asthma phenotype in an aller-
gen-dependent manner. When mothers and offspring were sensitized 
to the same allergen, airway inflammation in OVA-OVA offspring was 
more severe. This was evidenced by altered antibody concentrations, in-
creased BAL inflammatory cell influx and decreased lung tissue and lung 
draining lymph node FoxP3 cell frequency. When mothers and offspring 
were sensitized to different allergens (CAS-OVA), these differences 
were no longer apparent compared to the sham-OVA offspring group.
3.3 | Maternal allergic airway inflammation during 
pregnancy is associated with changes in maternal 
serum IgG1 and IgG3 glycosylation that persist in 
adult allergic offspring
It is established that glycosylation patterns influence the inflamma-
tory properties of IgG antibodies, and altered antibody glycosylation 
patterns are commonly observed in inflammatory diseases.28,29 For 
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F I G U R E  3   Recall allergen challenge of sensitized dams generates robust allergic airway inflammation that is similar in OVA and CAS 
allergic groups. Pregnant mice were sensitized with either PBS (sham), CAS or OVA before mating, then challenged during pregnancy 
with PBS, CAS or OVA, respectively. After the offspring were weaned, dams were recall challenged with PBS or the respective allergen. 
A, Maternal serum OVA-specific IgG1, OVA-specific IgE, CAS-specific IgG1, CAS-specific IgE. B, Maternal BAL numbers of leucocytes, 
eosinophils, lymphocytes and macrophages. C, Quantification of maternal lung inflammation. D, Lung histology images from control, CAS 
and OVA allergic mothers. Scale bar = 100µm. nd = not detectable, ns = not significant. Means ± SEM are shown, sham (n ≥ 8), CAS (n ≥ 8), 
OVA (n ≥ 8). Results represent two independently performed experiments. Significance is represented by *P < .05, **P < .01, ***P < .001, 
ANOVA or Kruskal-Wallis with Dunnett's multiple comparisons test
F I G U R E  4   Increased lung inflammation is observed in OVA allergic offspring from OVA allergic dams. Graphs show OVA allergic 
offspring from sham-treated dams or dams with allergic airway inflammation to either CAS or OVA during pregnancy. A, Total serum IgG1, 
OVA-specific IgG1 and OVA-specific IgE. B, Differential cell counts in the BAL: leucocytes, eosinophils, lymphocytes and macrophages. C, 
Quantification of lung tissue and lung draining lymph node FoxP3 staining from OVA allergic offspring. D, Representative images of offspring 
lung tissue immunohistochemistry—OVA allergic offspring from sham-treated and allergic mothers. Scale bar = 100 µm. Means ± SEM are 
shown, sham-OVA (n = 16), CAS-OVA (n = 17), OVA-OVA (n = 15). In each group, a minimum of 2 offspring from at least 6 different mothers 
were included. Results represent two independently performed experiments. Significance is represented by *P < .05, **P < .01, ***P < .001, 
ANOVA or Kruskal-Wallis with Dunnett's multiple comparisons test
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this reason, we next examined Asn-297 IgG antibody glycosylation 
in both maternal and offspring sera as a possible mediator for the 
increased airway inflammation observed in our OVA-OVA offspring. 
In OVA allergic mothers, analysis of IgG1 glycosylation patterns re-
vealed significantly increased levels of pro-inflammatory G0 com-
pared to CAS allergic dams (Figure 5A). Analysis of the offspring of 
these mothers revealed an amplification of this effect, with OVA-
OVA offspring having significantly increased levels of G0 compared 
to both sham-OVA and CAS-OVA offspring (Figure 5B).
The addition of sialic acid to the IgG Asn-297 region is strongly 
anti-inflammatory, and reduced sialylation is associated with a pro-in-
flammatory phenotype.30 In our study, analysis of maternal sialylation 
revealed that OVA allergic dams had significantly decreased percent-
ages of IgG1 sialic acid residues, including G1S1, G2S1, G3S1 and G2S2 
compared to the sham-sensitized group (Figure 5A). Though a similar 
trend was apparent in IgG1 sialylation in CAS allergic dams, only G3S1 
and G2S2 were significant. Examination of the offspring IgG1 revealed 
that these sialic acid reductions were mirrored and amplified in adult al-
lergic offspring. The strongest decreases were observed when mother 
and offspring were sensitized to the same allergen (OVA-OVA) with 
G1S1, G2S1, G3S1 and G2S2 being significantly reduced compared to 
sham-OVA offspring. When mother and offspring were sensitized to 
different allergens (CAS-OVA), decreases in offspring IgG1 sialylation 
were also observed, but to a lesser extent (Figure 5B).
In addition to IgG1, IgG3 antibodies also showed altered glycosyla-
tion patterns. Though there were no differences in pro-inflammatory 
G0 between any of the groups, anti-inflammatory sialylation (G1S1 
and G2S1) was significantly decreased in OVA mothers and their OVA 
allergic offspring. It is notable that no differences were observed in 
CAS mothers or CAS-OVA offspring when compared to sham-ex-
posed mothers or sham-OVA offspring, respectively (Figure 6A,B).
3.4 | Maternal serum IgG1 glycosylation 
percentages are strongly correlated with IgG1 
glycosylation percentages in adult allergic offspring
To better assess the relationship between maternal and offspring 
IgG glycosylation patterns, we next calculated Pearson correlation 
coefficients for IgG1 and IgG3 glycosylation subtypes. As shown in 
F I G U R E  5   Serum IgG1 antibodies from allergic mothers and their adult allergic offspring have significantly increased pro-inflammatory 
(agalactosylated) and reduced anti-inflammatory (sialylated) glycans. A, Asn-297 glycosylation of maternal serum IgG1 antibodies from sham-
treated, as well as CAS and OVA allergic mothers. B, Asn-297 glycosylation of serum IgG1 antibodies from OVA allergic offspring derived 
from sham-treated, CAS or OVA allergic mothers. Means ± SEM are shown: maternal sham (n = 5), maternal CAS (n = 5), maternal OVA (n = 5), 
sham-OVA offspring (n = 10), CAS-OVA offspring (n = 11) and OVA-OVA offspring (n = 10). Results represent two independently performed 
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Figure 7A, maternal and offspring IgG1-G0 percentages were sig-
nificantly correlated, with a moderate r of 0.43. Supporting our hy-
pothesis further, in all sialylated IgG1 groups, mothers and offspring 
were significantly and strongly correlated, with r ranging from 0.74 
to 0.89. Contrarily, measurement of IgG3 correlation between moth-
ers and offspring revealed that only IgG3-G1S1 was significant with 
a moderate r of 0.37 (Figure 7B). These data indicate that aglyco-
sylated and sialylated IgG1 percentages are strongly correlated be-
tween mothers and their adult allergic offspring.
In summary, analysis of IgG1 Asn-297 glycosylation patterns re-
vealed that 1) allergic dams have increased pro-inflammatory (G0) 
and decreased anti-inflammatory (sialic acid) glycan structures in the 
Fc region compared to sham controls, 2) the imbalance of pro- and 
anti-inflammatory IgG is aggravated in OVA allergic mothers com-
pared with CAS allergic mothers, and 3) the IgG1 glycosylation pat-
terns found in the mothers persisted in adult allergic offspring.
4  | DISCUSSION
Using a mouse model, we demonstrate here that maternal allergic 
airway inflammation during pregnancy is associated with an in-
creased airway inflammation in the offspring. Further, the extent 
of this response was clearly associated with mothers and offspring 
being sensitized to the same allergen (OVA-OVA). In contrast to CAS-
OVA offspring, OVA-OVA offspring had significantly increased aller-
gic airway inflammation and decreased numbers of pulmonary Treg 
cells compared to sham-OVA offspring. Glycosylation patterns in 
OVA mothers and their OVA allergic offspring were also significantly 
more pro-inflammatory than in the CAS-OVA or sham-OVA group.
Analysis of the humoral immune response revealed that CAS-
OVA offspring had significantly increased levels of total IgG1, and 
both CAS-OVA and OVA-OVA had significantly increased OVA-
specific IgG1 in the serum, compared to sham-OVA allergic offspring. 
OVA-specific serum IgE, however, was significantly decreased in 
OVA-OVA offspring. While decreased allergen-specific IgE titres 
may initially seem counterintuitive for an asthma risk model, this 
is likely because both mother and offspring were sensitized to the 
same allergen. Supporting this, Jarrett and Hall showed in rats that 
maternal sensitization with OVA before pregnancy resulted in sup-
pression of OVA-specific IgE and enhanced production of IgG in 
OVA-sensitized pups. The effect was allergen-specific as maternal 
immunization with keyhole limpet haemocyanin did not suppress IgE 
in the offspring.31 As the underlying mechanisms of offspring IgE 
suppression are not fully understood, our model provides an excel-
lent opportunity to further study this phenomenon.
An additional puzzling aspect of our study was the question of 
how maternal allergy led to differential allergen-specific effects 
F I G U R E  6   Serum IgG3 antibodies 
from OVA allergic mothers and their adult 
OVA allergic offspring have significantly 
reduced anti-inflammatory (sialylated) 
glycans. A, Asn-297 glycosylation of 
maternal serum IgG3 antibodies from 
sham-treated, as well as CAS and OVA 
allergic mothers. B, Asn-297 glycosylation 
of serum from OVA allergic offspring 
derived from sham-treated, CAS or OVA 
allergic mothers. Means ± SEM are shown: 
maternal sham (n = 5), maternal CAS 
(n = 5), maternal OVA (n = 5), sham-OVA 
offspring (n = 10), CAS-OVA offspring 
(n = 11) and OVA-OVA offspring (n = 10). 
Results represent two independently 
performed experiments. Significance is 
represented by *P < .05, **P < .01, ANOVA 
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in the offspring. We propose for the first time that IgG antibody 
glycosylation is an important additional factor that could sub-
stantially contribute to distinct aspects of the asthma phenotype. 
Glycosylation is a critical posttranslational protein modification, and 
it has been described that N-linked glycans in the Fc region influ-
ence antibody effector functions. The addition of sialic acid residues 
onto these glycan chains generates IgG molecules that bind mouse 
Icam-3 grabbing non–integrin-related 1 (SIGNR1), which actively in-
duces an anti-inflammatory cascade.30 Illustrating this, successful al-
lergen-specific immunotherapy in allergic patients is correlated with 
increased IgG sialylation.19,32 In our model of maternal transmission 
of asthma risk, the group with the most severe airway inflammation 
(OVA-OVA offspring) had significantly increased agalactosylated 
IgG1 levels as well as decreased sialic acid residues on both IgG1 
and IgG3 molecules, indicating a strong pro-inflammatory status. 
The CAS-OVA offspring, which showed a trend towards increased 
asthma severity, also had decreased IgG1 and IgG3 sialylation, 
though to a much lesser extent than the OVA-OVA offspring. Thus, 
maternal allergic airway inflammation during pregnancy was associ-
ated with decreased frequencies of protective IgG antibodies in the 
offspring.
Finally, to explore the relationship between mother and off-
spring, we also examined serum IgG glycosylation in asthmatic 
dams which were recall challenged to allergen. Maternal IgG1 
serum glycosylation patterns strongly correlated with the patterns 
observed in allergic offspring. This indicates that maternal IgG 
antibodies may play a role in offspring allergy development, and 
highlights the importance of measuring antibody glycosylation in 
addition to concentration in allergy studies. Our results highlight a 
key role for IgG glycosylation in the transgenerational transmission 
F I G U R E  7   Maternal serum Asn-297 IgG1 glycosylation percentages are strongly correlated with adult allergic offspring IgG1 
glycosylation percentages. Correlation analysis showing A) correlation between maternal and adult allergic offspring IgG1 glycosylation 
percentages and B) correlation between maternal and adult allergic offspring IgG3 glycosylation percentages. Sham-OVA offspring (n = 10), 
CAS-OVA offspring (n = 11), OVA-OVA offspring (n = 10) compared with their respective mothers. Correlation is given in Pearson's r
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of offspring asthma risk that warrants further investigation. Since 
the current study measured IgG glycosylation in recall challenged 
mothers and adult allergic offspring, future studies will include 
analyses of mothers and offspring at several gestational and neo-
natal time points. Our newly developed mouse model provides a 
resource to understand in more detail how maternal IgG glyco-
sylation during pregnancy influences offspring immune system de-
velopment and subsequent susceptibility to inflammatory diseases 
such as asthma later in life.
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